These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37334761)

  • 1. Home-based diphenylcyclopropenone immunotherapy for alopecia areata: A large retrospective study of 94 cases.
    Nam KH; Lee GJ; Kim JI; Song KH; Park J
    J Dermatol; 2023 Aug; 50(8):1093-1095. PubMed ID: 37334761
    [No Abstract]   [Full Text] [Related]  

  • 2. Home-based contact immunotherapy with diphenylcyclopropenone for alopecia areata is as effective and safe as clinic-based treatment in patients with stable disease: A retrospective study of 40 patients.
    Lee S; Lee WS
    J Am Acad Dermatol; 2018 Mar; 78(3):599-601.e1. PubMed ID: 28947296
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical immunotherapy with diphenylcyclopropenone in patients with alopecia areata: A large retrospective study of 757 patients.
    Nasimi M; Abedini R; Ghandi N; Seirafi H; Mehdizade MS; Tootoonchi N
    Dermatol Ther; 2020 Nov; 33(6):e13808. PubMed ID: 32530566
    [No Abstract]   [Full Text] [Related]  

  • 4. Acquired hair curling after diphenylcyclopropenone immunotherapy in alopecia areata patient.
    Choe SJ; Kim BJ; Choi J; Lee WS
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):e371-e372. PubMed ID: 28191673
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythema Multiforme Major After Immunotherapy With Diphenylcyclopropenone for Alopecia Areata.
    Sanger J; Zahir A; Driscoll M; Gaspari AA
    Dermatitis; 2018; 29(6):348-349. PubMed ID: 30346328
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical immunotherapy with diphenylcyclopropenone-induced vitiligo.
    Kutlubay Z; Engin B; Songur A; Serdaroglu S; Tuzun Y
    J Cosmet Laser Ther; 2016 Aug; 18(4):245-6. PubMed ID: 26963903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of alopecia areata with topical sensitizers.
    Sutherland L; Laschinger M; Syed ZU; Gaspari A
    Dermatitis; 2015; 26(1):26-31. PubMed ID: 25581667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Durdu M; Özcan D; Baba M; Seçkin D
    J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
    Aghaei S
    BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
    Galadari I; Rubaie S; Alkaabi J; Galadari H
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of alopecia areata with diphenylcyclopropenone.
    Kietzmann H; Hardung H
    Acta Derm Venereol; 1985; 65(3):274-5. PubMed ID: 2411093
    [No Abstract]   [Full Text] [Related]  

  • 13. DPCP for the treatment of alopecia areata.
    Bolduc C; Shapiro J
    Skin Therapy Lett; 2000; 5(5):3-4. PubMed ID: 10854342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of alopecia areata with diphenylcyclopropenone.
    Hull SM; Cunliffe WJ
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):276-7. PubMed ID: 1552076
    [No Abstract]   [Full Text] [Related]  

  • 15. Possible advantage of imiquimod and diphenylcyclopropenone combined treatment versus diphenylcyclopropenone alone: An observational study of nonresponder patients with alopecia areata.
    Wasyłyszyn T; Borowska K
    Australas J Dermatol; 2017 Aug; 58(3):219-223. PubMed ID: 27087586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited efficacy of diphenylcyclopropenone in the treatment of alopecia areata: Experience from a Tertiary Healthcare Institution in Singapore.
    Leong WMS; Mok ZR; Chandran NS
    Dermatol Ther; 2020 Nov; 33(6):e14447. PubMed ID: 33098604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata.
    Jang YH; Jung HJ; Moon SY; Lee WJ; Lee SJ; Lee WK; Kim DW
    J Am Acad Dermatol; 2017 Jul; 77(1):170-172.e1. PubMed ID: 28619558
    [No Abstract]   [Full Text] [Related]  

  • 18. A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata.
    Al Bazzal A; Hatami P; Abedini R; Etesami I; Ayanian Z; Ghandi N
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108186. PubMed ID: 34710658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata--a large retrospective study on 142 patients with a self-controlled design.
    Ohlmeier MC; Traupe H; Luger TA; Böhm M
    J Eur Acad Dermatol Venereol; 2012 Apr; 26(4):503-7. PubMed ID: 21569118
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.